US Patent Issued to University-Industry Cooperation Group of Kyung Hee University, NAVIPHARM on Oct. 21 for "Lactic acid bacteria and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,184, issued on Oct. 21, was assigned to University-Industry Cooperation Group of Kyung Hee University (Gyeonggi-do, South Korea) and NAVIPHARM Co. LTD. (Gyeonggi-do, South Korea).

"Lactic acid bacteria and use thereof" was invented by Dong-Hyun Kim (Seoul, South Korea) and Myung Joo Han (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel lactic acid bacterium, and more particularly, to a composition comprising Lactobacillus reuteri NK33 (KCCM12090P) or Bifidobacterium adolescentis NK98 (KCCM12297P), which is the novel lactic acid bacterium, useful in preventing and treating a neurological menta...